Piramal Enterprises Limited (PEL.NS)

INR 978.0

(1.04%)

Operating Income Summary of Piramal Enterprises Limited

  • Piramal Enterprises Limited's latest annual operating income in 2023 was - INR , down -146.35% from previous year.
  • Piramal Enterprises Limited's latest quarterly operating income in 2024 Q2 was 14.66 Billion INR , up 517.51% from previous quarter.
  • Piramal Enterprises Limited reported an annual operating income of 44.85 Billion INR in 2022, down -30.79% from previous year.
  • Piramal Enterprises Limited reported an annual operating income of 64.8 Billion INR in 2021, down -6.47% from previous year.
  • Piramal Enterprises Limited reported a quarterly operating income of -3.51 Billion INR for 2024 Q1, up 81.15% from previous quarter.
  • Piramal Enterprises Limited reported a quarterly operating income of 31.99 Billion INR for 2023 Q1, up 2689.75% from previous quarter.

Annual Operating Income Chart of Piramal Enterprises Limited (2023 - 2004)

Historical Annual Operating Income of Piramal Enterprises Limited (2023 - 2004)

Year Operating Income Operating Income Growth
2023 - INR -146.35%
2022 44.85 Billion INR -30.79%
2021 64.8 Billion INR -6.47%
2020 69.28 Billion INR 16.98%
2019 59.22 Billion INR -11.39%
2018 66.84 Billion INR 29.34%
2017 51.68 Billion INR 48.46%
2016 34.81 Billion INR 75.85%
2015 19.79 Billion INR -45.77%
2014 36.5 Billion INR 930.03%
2013 3.54 Billion INR 26.36%
2012 2.8 Billion INR -15.67%
2011 3.32 Billion INR -98.0%
2010 166.63 Billion INR 2808.21%
2009 5.72 Billion INR 69.43%
2008 3.38 Billion INR -8.95%
2007 3.71 Billion INR 44.56%
2006 2.56 Billion INR 77.86%
2005 1.44 Billion INR -31.38%
2004 2.1 Billion INR 0.0%

Peer Operating Income Comparison of Piramal Enterprises Limited

Name Operating Income Operating Income Difference
Amrutanjan Health Care Limited 621.02 Million INR 100.0%
Biofil Chemicals and Pharmaceuticals Limited 20.65 Million INR 100.0%
Caplin Point Laboratories Limited 7.22 Billion INR 100.0%
FDC Limited 3.03 Billion INR 100.0%
Gufic Biosciences Limited 2.89 Billion INR 100.0%
Hikal Limited 1.49 Billion INR 100.0%
Ind-Swift Laboratories Limited 2 Billion INR 100.0%
IOL Chemicals and Pharmaceuticals Limited 4.94 Billion INR 100.0%
Kilitch Drugs (India) Limited 208.05 Million INR 100.0%
Medico Remedies Limited 277.11 Million INR 100.0%
Nectar Lifesciences Limited 3.89 Billion INR 100.0%
Par Drugs and Chemicals Limited 551.58 Million INR 100.0%
RPG Life Sciences Limited 2.29 Billion INR 100.0%
Sequent Scientific Limited - INR NaN%
Shilpa Medicare Limited 3.76 Billion INR 100.0%
Sigachi Industries Limited 1.47 Billion INR 100.0%
Themis Medicare Limited 1.3 Billion INR 100.0%
Unichem Laboratories Limited - INR NaN%
Venus Remedies Limited 534.65 Million INR 100.0%
Wanbury Limited 1.7 Billion INR 100.0%
ZIM Laboratories Limited 1.09 Billion INR 100.0%
Lupin Limited 27.75 Billion INR 100.0%
Innova Captab Limited 2.53 Billion INR 100.0%
Ind-Swift Limited 1.22 Billion INR 100.0%
Bajaj HealthCare Limited - INR NaN%
Aurobindo Pharma Limited 104.5 Billion INR 100.0%
Solara Active Pharma Sciences Limited -3.85 Billion INR 100.0%
AstraZeneca Pharma India Limited 4.47 Billion INR 100.0%
Mangalam Drugs & Organics Limited 27.45 Million INR 100.0%
Morepen Laboratories Limited 4.17 Billion INR 100.0%
Laurus Labs Limited 3.94 Billion INR 100.0%
Aarti Drugs Limited 7.14 Billion INR 100.0%
Glenmark Life Sciences Limited 8.97 Billion INR 100.0%
Alembic Limited 767.77 Million INR 100.0%
Alembic Pharmaceuticals Limited 5.75 Billion INR 100.0%
Glenmark Pharmaceuticals Limited 6.5 Billion INR 100.0%
Vaishali Pharma Limited 6.29 Million INR 100.0%
Aarti Pharmalabs Limited 3.12 Billion INR 100.0%
Jagsonpal Pharmaceuticals Limited 214.04 Million INR 100.0%
Jubilant Pharmova Limited 5.18 Billion INR 100.0%
Eris Lifesciences Limited 5.18 Billion INR 100.0%
Windlas Biotech Limited 1.29 Billion INR 100.0%
Sun Pharmaceutical Industries Limited 104.3 Billion INR 100.0%
Lincoln Pharmaceuticals Limited 1.9 Billion INR 100.0%
Orchid Pharma Limited 2.36 Billion INR 100.0%
Albert David Limited 1.33 Billion INR 100.0%
Hester Biosciences Limited 364.77 Million INR 100.0%
Sakar Healthcare Limited 495.5 Million INR 100.0%
Suven Pharmaceuticals Limited 4.6 Billion INR 100.0%
Procter & Gamble Health Limited 2.78 Billion INR 100.0%
Divi's Laboratories Limited 18.31 Billion INR 100.0%
Mankind Pharma Limited 40.86 Billion INR 100.0%
Neuland Laboratories Limited 5.31 Billion INR 100.0%
J. B. Chemicals & Pharmaceuticals Limited 7.54 Billion INR 100.0%
Zydus Lifesciences Limited 45.39 Billion INR 100.0%
Wockhardt Limited 140 Million INR 100.0%
Bal Pharma Limited 214.56 Million INR 100.0%
Dr. Reddy's Laboratories Limited 67.72 Billion INR 100.0%
Bliss GVS Pharma Limited 1.23 Billion INR 100.0%
Alkem Laboratories Limited 19.46 Billion INR 100.0%
Valiant Laboratories Limited - INR NaN%
Ajanta Pharma Limited 19.67 Billion INR 100.0%
Bafna Pharmaceuticals Limited 237.66 Million INR 100.0%
Aarey Drugs & Pharmaceuticals Limited 2.83 Million INR 100.0%
Granules India Limited 6.52 Billion INR 100.0%
Medicamen Biotech Limited - INR NaN%
Ipca Laboratories Limited 29.59 Billion INR 100.0%
Brooks Laboratories Limited -72.25 Million INR 100.0%
Syncom Formulations (India) Limited 249.25 Million INR 100.0%
Torrent Pharmaceuticals Limited 25.33 Billion INR 100.0%
NATCO Pharma Limited 25.96 Billion INR 100.0%
Suven Life Sciences Limited -1.22 Billion INR 100.0%
Krebs Biochemicals & Industries Limited - INR NaN%
Strides Pharma Science Limited 5.22 Billion INR 100.0%
Indoco Remedies Limited 1.52 Billion INR 100.0%
Alpa Laboratories Limited 61.51 Million INR 100.0%
Lasa Supergenerics Limited -458 Million INR 100.0%
Sun Pharma Advanced Research Company Limited -4.11 Billion INR 100.0%